BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10518614)

  • 1. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation.
    Bianchi L; Tacchini L; Cairo G
    Nucleic Acids Res; 1999 Nov; 27(21):4223-7. PubMed ID: 10518614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation.
    Tacchini L; Bianchi L; Bernelli-Zazzera A; Cairo G
    J Biol Chem; 1999 Aug; 274(34):24142-6. PubMed ID: 10446187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency.
    Mukhopadhyay CK; Mazumder B; Fox PL
    J Biol Chem; 2000 Jul; 275(28):21048-54. PubMed ID: 10777486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel iron chelator that does not induce HIF-1 activity.
    Creighton-Gutteridge M; Tyrrell RM
    Free Radic Biol Med; 2002 Aug; 33(3):356-63. PubMed ID: 12126757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin receptor gene expression and transferrin-bound iron uptake are increased during postischemic rat liver reperfusion.
    Tacchini L; Fusar Poli D; Bernelli-Zazzera A; Cairo G
    Hepatology; 2002 Jul; 36(1):103-11. PubMed ID: 12085354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a hypoxia response element in the transferrin receptor gene.
    Lok CN; Ponka P
    J Biol Chem; 1999 Aug; 274(34):24147-52. PubMed ID: 10446188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.
    An WG; Kanekal M; Simon MC; Maltepe E; Blagosklonny MV; Neckers LM
    Nature; 1998 Mar; 392(6674):405-8. PubMed ID: 9537326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.
    Martin F; Linden T; Katschinski DM; Oehme F; Flamme I; Mukhopadhyay CK; Eckhardt K; Tröger J; Barth S; Camenisch G; Wenger RH
    Blood; 2005 Jun; 105(12):4613-9. PubMed ID: 15741220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity.
    Agani F; Semenza GL
    Mol Pharmacol; 1998 Nov; 54(5):749-54. PubMed ID: 9804609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1.
    Rolfs A; Kvietikova I; Gassmann M; Wenger RH
    J Biol Chem; 1997 Aug; 272(32):20055-62. PubMed ID: 9242677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines.
    Furukawa T; Adachi Y; Fujisawa J; Kambe T; Yamaguchi-Iwai Y; Sasaki R; Kuwahara J; Ikehara S; Tokunaga R; Taketani S
    Oncogene; 2001 Aug; 20(34):4718-27. PubMed ID: 11498794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency can upregulate expression of transferrin receptor at both the mRNA and protein level.
    Tong X; Kawabata H; Koeffler HP
    Br J Haematol; 2002 Feb; 116(2):458-64. PubMed ID: 11841452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia.
    Obach M; Navarro-Sabaté A; Caro J; Kong X; Duran J; Gómez M; Perales JC; Ventura F; Rosa JL; Bartrons R
    J Biol Chem; 2004 Dec; 279(51):53562-70. PubMed ID: 15466858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic regulation of angiopoietin-2 expression in endothelial cells.
    Pichiule P; Chavez JC; LaManna JC
    J Biol Chem; 2004 Mar; 279(13):12171-80. PubMed ID: 14702352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells.
    Dimova EY; Möller U; Herzig S; Fink T; Zachar V; Ebbesen P; Kietzmann T
    Thromb Haemost; 2005 Jun; 93(6):1176-84. PubMed ID: 15968405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
    Jones DT; Trowbridge IS; Harris AL
    Cancer Res; 2006 Mar; 66(5):2749-56. PubMed ID: 16510596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter.
    Grosfeld A; Andre J; Hauguel-De Mouzon S; Berra E; Pouyssegur J; Guerre-Millo M
    J Biol Chem; 2002 Nov; 277(45):42953-7. PubMed ID: 12215445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A zinc-finger protein, PLAGL2, induces the expression of a proapoptotic protein Nip3, leading to cellular apoptosis.
    Mizutani A; Furukawa T; Adachi Y; Ikehara S; Taketani S
    J Biol Chem; 2002 May; 277(18):15851-8. PubMed ID: 11832486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.